Catalent Inc
NYSE:CTLT

Watchlist Manager
Catalent Inc Logo
Catalent Inc
NYSE:CTLT
Watchlist
Price: 63.48 USD Market Closed
Market Cap: 11.5B USD

Intrinsic Value

The intrinsic value of one CTLT stock under the Base Case scenario is hidden USD. Compared to the current market price of 63.48 USD, Catalent Inc is hidden .

CTLT Intrinsic Value
HIDDEN
Show
Base Case Scenario

Valuation History
Catalent Inc

Intrinsic Value History
Dive into the past to invest in the future

CTLT looks overvalued. Yet it might still be cheap by its own standards. Some stocks live permanently above intrinsic value; Historical Valuation reveals whether CTLT usually does or if today's premium is unusual.

Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Show Historical Valuation
What is Valuation History?
Ask AI Assistant
What other research platforms think about CTLT?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is CTLT valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for Catalent Inc.

Explain Valuation
Compare CTLT to
Custom
Choose any stock to compare

Fundamental Analysis

CTLT Profitability Score
Profitability Due Diligence

Loading...
Loading...
Loading...
Loading...
Profitability
Score

CTLT Solvency Score
Solvency Due Diligence

Loading...
Loading...
Loading...
Loading...
Solvency
Score
Company Overview
Loading...
Business Segments
Loading...
Economic Moat
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
Bear Theses

Strained relationships with key biotech clients, stemming from recent production delays and cost overruns, could lead to the loss of long-term contracts and hamper Catalent’s ability to secure profitable extensions in its manufacturing pipeline.

Bull Theses

Catalent’s specialized biologics capabilities and ongoing capacity expansions in gene and cell therapy position the company to capture new, high-margin business from emerging biotech innovators and established pharmaceutical players alike.

Show More Less
How do you feel about CTLT?
Bearish
Neutral
Bullish
Efficiency

Free Cash Flow Analysis
Catalent Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate

Wall St
Price Targets

CTLT Price Targets Summary
Catalent Inc

There are no price targets for CTLT.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates

Dividends

Catalent Inc
does not pay dividends
Shareholder Yield

Current shareholder yield for CTLT is hidden .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
HIDDEN
Show
Dividend Yield
No dividends
Buyback Yield
HIDDEN
Debt Paydown Yield
HIDDEN

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y

Ownership

CTLT Insider Trading
Buy and sell transactions by insiders

CTLT News

Other Videos
What is the Intrinsic Value of one CTLT stock?

The intrinsic value of one CTLT stock under the Base Case scenario is hidden USD.

Is CTLT stock undervalued or overvalued?

Compared to the current market price of 63.48 USD, Catalent Inc is hidden .

Back to Top